JAK3 inhibitor (Hunan Nucien Pharmaceutical)

N/A

Report date: 2025/01/26 18:15:57
NME

Base Information

Drug NameJAK3 inhibitor (Hunan Nucien Pharmaceutical)
Drug Alias Namedual JAK3/TEC inhibitor (Hunan Nucien Pharmaceutical)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionTec protein tyrosine kinase inhibitorsTyrosine-protein kinase JAK3 inhibitors
TargetsTyrosine-protein kinase TecTyrosine-protein kinase JAK3
Therapy Area/IndicationsOsteodystrophyVitiligoAlopecia +[7] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesHunan Nucien Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesHunan Nucien Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsOsteodystrophyVitiligoAlopecia +[6] 
Inactive IndicationsArthritis, Rheumatoid

Other Information

ATC CodeN/A
Related LinksN/A